Nutramin Vli (Valine, Isoleucine, Leucine)

Nutramin Vli is used as an intravenous amino acid supplement that supports protein synthesis pathways in clinical nutrition.

• Critical illness: Helps maintain lean body mass during intensive care stays.
• Post‑operative recovery: Provides essential amino acids to aid tissue repair after surgery.
• Malnutrition associated with chronic disease: Supplies needed branched‑chain amino acids to support nutritional status.

• The branched‑chain amino acids valine, isoleucine and leucine are taken up by skeletal muscle and other tissues, where they stimulate the mTOR signaling pathway and serve as substrates for protein synthesis, thereby supporting lean tissue maintenance and nitrogen balance during periods of catabolic stress.

Adverse reactions to intravenous amino acid mixtures are generally infrequent but may occur.

Common Side Effects

• Mild infusion site erythema
• Transient nausea
• Slight increase in serum ammonia levels
• Temporary headache
• Mild electrolyte shift
• Low-grade fever

Serious or Rare Side Effects

• Anaphylactic reaction
• Severe hyperammonemia
• Acute renal impairment
• Metabolic acidosis
• Severe electrolyte disturbances
• Cardiovascular collapse

When using Nutramin Vli, clinicians should consider patient‑specific factors and monitor relevant parameters.

• Renal function: Assess baseline creatinine and adjust infusion rate if impairment is present.
• Hepatic function: Monitor liver enzymes and ammonia levels in patients with liver disease.
• Electrolyte balance: Check serum electrolytes before and during therapy.
• Metabolic status: Observe for signs of hyperammonemia or acidosis.
• Pregnancy and lactation: Use only if clearly beneficial.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct light.

Nutramin Vli may interact with other agents that influence amino acid metabolism or electrolyte balance.

Major Interactions (Avoid)

• High‑dose nitrogen‑based waste‑products (e.g., urea supplements) that could exacerbate hyperammonemia.
• Certain antihybran  

Moderate  

t  

-